Metformin

Generic Name
Metformin
Brand Names
Actoplus Met, Avandamet, Fortamet, Glucophage, Glucovance, Glumetza, Glycon, Invokamet, Janumet, Jentadueto, Kazano, Kombiglyze, Komboglyze, Qternmet, Riomet, Segluromet, Synjardy, Trijardy, Velmetia, Xigduo
Drug Type
Small Molecule
Chemical Formula
C4H11N5
CAS Number
657-24-9
Unique Ingredient Identifier
9100L32L2N
Background

Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the management of type II diabetes.
...

Indication

Metformin immediate-release formulations

Metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients ≥10 years old with type 2 diabetes mellitus.

Metformin extended-release tablet (XR)
...

Associated Conditions
Cardiovascular Mortality, End Stage Renal Disease (ESRD), Hospitalizations, Polycystic Ovarian Syndrome (PCOS), Type 2 Diabetes Mellitus, Decreased estimated glomerular filtration rate
Associated Therapies
-
statnews.com
·

What to know about RFK Jr.'s views on food, vaccines, abortion, and the FDA

Trump nominates RFK Jr. to lead HHS, aiming to reshape public health agencies and vaccine policies. RFK Jr. plans to restructure HHS, remove ultra-processed foods, and address environmental factors like fluoridation. He advocates for transparency in vaccine data and opposes legal protections for vaccine makers. His potential influence on vaccine uptake and institutional reforms at health agencies raises concerns among public health experts.
rollcall.com
·

Age of biology requires American leadership

Russia is rebuilding a biological weapons research center, while China's dominance in biotech supply chains poses economic threats. The U.S. must lead in biotechnology to prevent adversaries from undermining global priorities. The National Security Commission on Emerging Biotechnology (NSCEB) aims to strengthen America's biotech leadership through a report detailing necessary actions. The U.S. faces a biotechnology supply chain vulnerability due to reliance on Chinese companies, which the BIOSECURE Act seeks to address. Accelerating biotech innovation domestically and collaborating with allies are crucial for maintaining global biotech leadership. The federal government needs to better support biotech companies and streamline regulations. The NSCEB's forthcoming report will focus on policies to promote and protect American biotechnology.
theconversation.com
·

New study suggests weight loss drugs like Ozempic could help with knee pain. Here's why ...

Semaglutide, originally for type 2 diabetes, shows promise in reducing knee pain from osteoarthritis, with participants losing 13% body weight on average, compared to 3% with placebo. The drug's anti-inflammatory properties and potential to protect cartilage are suggested mechanisms, though independent studies are needed. Side effects and accessibility remain concerns.
journals.plos.org
·

Anchorage of bacterial effector at plasma membrane via selective phosphatidic acid binding

Bacterial effectors anchor to host cell membranes via binding phosphatidic acid (PA), identified in Bartonella T4SS effectors (Beps). The C-terminal BID domain directs Beps' plasma membrane localization through PA binding, with mutations disrupting electrostatic interactions preventing anchorage. Disassociation from the plasma membrane attenuates BepC's ability to induce stress fiber formation and cell fragmentation, while BepD's cytosolic localization is crucial for modulating host immune responses. The study reveals PA-binding properties of bacterial effectors for plasma membrane localization, shedding light on their mechanisms within host cells.
pharmaphorum.com
·

The evolving role of AI in drug submission and approval: An expert perspective

AI transforms pharmaceutical industry by accelerating drug discovery, improving accuracy, ensuring real-time compliance, and streamlining documentation. Challenges include data quality, transparency, and regulatory frameworks. Upskilling through role-based simulations and AI chatbots is crucial for effective AI integration, enhancing collaboration, engagement, and efficiency.

Lack of pragmatic attitude of self-labelled pragmatic trials on manual therapy

Article references on pragmatic trials, focusing on pain therapies, manual therapy, and the importance of decision intent within descriptions of pragmatic trials.

Personalized Medicine: Past, Present, and Future

In 2000, President Clinton celebrated the first survey of the human genome, predicting it would revolutionize medicine. Despite initial skepticism, personalized medicine gained traction, driven by advancements in diagnostics and targeted therapies. Challenges remain in regulatory frameworks and healthcare infrastructure, but the promise of personalized, predictive, and preventive medicine continues to evolve.
nature.com
·

How 'miracle' weight-loss drugs will change the world

GLP-1 agonists, like semaglutide, could transform societies by reducing obesity, saving trillions, and improving quality of life, but uncertainties remain regarding long-term effects, cost, and behavioral changes.
clinicalleader.com
·

How Can "The Godfather Of Influence" Help Improve Clinical Trial Recruitment

Article explores applying Robert Cialdini's 'Influence' principles to patient recruitment, contrasting modern approaches with traditional methods through hypothetical interviews. Candidate One advocates for personalized value, small commitments, social proof, and authority, while Candidate Two prefers standard, less engaging practices. The article concludes that investing in modern recruitment strategies is crucial for trial success.
© Copyright 2024. All Rights Reserved by MedPath